Jiangsu Hengrui Me. traded at 41.66 this Tuesday March 21st, increasing 1.26 or 3.12 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui Me. gained 5.55 percent. Over the last 12 months, its price rose by 12.78 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 39.74 by the end of this quarter and at 36.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
Daily Change

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Cspc Pharmaceutical 8.13 0.38 4.90% -6.66%
Sino Biopharmaceutical Ltd 4.36 0.10 2.35% -8.21%
Sh Fosun Pharma 32.09 0.66 2.10% -40.80%
Sh Pharmaceutical 20.50 -0.20 -0.97% -17.80%
WuXi AppTec Co Ltd 80.20 6.20 8.38% -22.08%

Indexes Price Day Year
SHANGHAI 3256 20.74 0.64% -0.13%
SHANGHAI 50 2643 26.61 1.02% -8.87%

Jiangsu Hengrui Me.
Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.